ArticleTheranostics2025

Apolipoprotein E promotes primary resistance to AR-targeted therapy via inducing TRIM25-mediated AR ubiquitination and sensitizes immunotherapy in prostate cancer.

Chaofan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.